Fig. 3From: PPARG is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformaticsPathological correlation of 9 Tanshinone IIA-associated key hub genes. A1–A9: the nine key hub genes are associated with pathological T stage; B1–B9: the nine key hub genes are associated with pathological N stage; C1–C9: the nine key hub genes are associated with pathological Gleason scoreBack to article page